PER 34.1% 8.9¢ percheron therapeutics limited

Ann: First Patient Dosed in ATL1102 Phase IIb DMD Trial, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,578 Posts.
    lightbulb Created with Sketch. 297
    Beetlejuice ?
    good news for the co and the patients. Start of maybe sp rescue
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.